Galapagos | GLPG - Gross Profit On Sales

Stock Price
28.18
Daily Change
-0.42 -1.47%
Monthly
0.50%
Yearly
27.63%
Q1 Forecast
27.75

Galapagos reported EUR-13.57M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
argenx SE USD 1.02B 180.32M Sep/2025
AstraZeneca USD 12.39B 406M Sep/2025
Biogen USD 1.65B 34.6M Dec/2025
Genmab DKK 868M 195M Jun/2025
Gilead Sciences USD 5.58B 453M Jun/2025
GlaxoSmithKline GBP 6.18B 106M Dec/2025
GRIFOLS EUR 743.8M 49.13M Jun/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Incyte USD 1.27B 130.22M Sep/2025
Merck EUR 3.21B 186M Sep/2025
Neurocrine Biosciences USD 780.9M 104.7M Sep/2025
Novartis USD 10.82B 695M Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
UCB EUR 2.46B 520M Dec/2024
Vertex Pharmaceuticals USD 2.66B 104.4M Sep/2025